Beech Hill Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $572K | Sell |
1,625
-100
| -6% | -$35.6K | 0.29% | 75 |
|
|
2025
Q4 | $565K | Hold |
1,725
| – | – | 0.27% | 76 |
|
|
2025
Q3 | $487K | Buy |
1,725
+225
| +15% | +$65.3K | 0.23% | 80 |
|
|
2025
Q2 | $419K | Hold |
1,500
| – | – | 0.19% | 84 |
|
|
2025
Q1 | $467K | Hold |
1,500
| – | – | 0.19% | 84 |
|
|
2024
Q4 | $391K | Buy |
1,500
+150
| +11% | +$44.5K | 0.15% | 90 |
|
|
2024
Q3 | $435K | Sell |
1,350
-800
| -37% | -$262K | 0.16% | 84 |
|
|
2024
Q2 | $672K | Hold |
2,150
| – | – | 0.28% | 70 |
|
|
2024
Q1 | $611K | Hold |
2,150
| – | – | 0.25% | 70 |
|
|
2023
Q4 | $619K | Hold |
2,150
| – | – | 0.3% | 64 |
|
|
2023
Q3 | $578K | Hold |
2,150
| – | – | 0.29% | 64 |
|
|
2023
Q2 | $477K | Sell |
2,150
-125
| -5% | -$29K | 0.23% | 69 |
|
|
2023
Q1 | $550K | Sell |
2,275
-31
| -1% | -$7.61K | 0.28% | 65 |
|
|
2022
Q4 | $606K | Sell |
2,306
-219
| -9% | -$58.7K | 0.34% | 62 |
|
|
2022
Q3 | $569K | Hold |
2,525
| – | – | 0.33% | 64 |
|
|
2022
Q2 | $614K | Sell |
2,525
-8
| -0.3% | -$1.96K | 0.33% | 67 |
|
|
2022
Q1 | $613K | Hold |
2,533
| – | – | 0.25% | 69 |
|
|
2021
Q4 | $570K | Hold |
2,533
| – | – | 0.22% | 74 |
|
|
2021
Q3 | $539K | Buy |
2,533
+8
| +0.3% | +$1.84K | 0.22% | 74 |
|
|
2021
Q2 | $615K | Buy |
2,525
+400
| +19% | +$98.4K | 0.25% | 66 |
|
|
2021
Q1 | $529K | Sell |
2,125
-58
| -3% | -$13.8K | 0.22% | 69 |
|
|
2020
Q4 | $502K | Sell |
2,183
-375
| -15% | -$86.5K | 0.22% | 67 |
|
|
2020
Q3 | $650K | Hold |
2,558
| – | – | 0.32% | 59 |
|
|
2020
Q2 | $603K | Hold |
2,558
| – | – | 0.31% | 56 |
|
|
2020
Q1 | $519K | Hold |
2,558
| – | – | 0.35% | 51 |
|
|
2019
Q4 | $617K | Hold |
2,558
| – | – | 0.29% | 53 |
|
|
2019
Q3 | $495K | Hold |
2,558
| – | – | 0.26% | 55 |
|
|
2019
Q2 | $471K | Buy |
2,558
+300
| +13% | +$53.7K | 0.25% | 60 |
|
|
2019
Q1 | $429K | Hold |
2,258
| – | – | 0.26% | 58 |
|
|
2018
Q4 | $440K | Hold |
2,258
| – | – | 0.27% | 53 |
|
|
2018
Q3 | $468K | Hold |
2,258
| – | – | 0.24% | 56 |
|
|
2018
Q2 | $417K | Hold |
2,258
| – | – | 0.23% | 55 |
|
|
2018
Q1 | $385K | Buy |
2,258
+255
| +13% | +$46.8K | 0.2% | 55 |
|
|
2017
Q4 | $348K | Hold |
2,003
| – | – | 0.17% | 66 |
|
|
2017
Q3 | $373K | Hold |
2,003
| – | – | 0.2% | 61 |
|
|
2017
Q2 | $345K | Buy |
2,003
+418
| +26% | +$68K | 0.19% | 65 |
|
|
2017
Q1 | $260K | Buy |
1,585
+170
| +12% | +$28.2K | 0.15% | 71 |
|
|
2016
Q4 | $207K | Buy |
+1,415
| New | +$213K | 0.12% | 79 |
|
Other funds holding AMGN
VCM
VPM
Beech Hill Advisors's AMGN Position: Q1 2026 in Review
Beech Hill Advisors reduced its Amgen (AMGN) stake by 5.8% in Q1 2026, selling an estimated $35.6K and leaving 1,625 shares worth $572K. The position accounts for 0.29% of the portfolio, ranked #75.
Beech Hill Advisors first reported a position in AMGN in Q4 2016 and has held it in 38 quarters since. The position peaked at $672K in Q2 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Beech Hill Advisors held 1,625 shares of Amgen worth $572K as of Q1 2026.
- Beech Hill Advisors sold 100 Amgen shares in Q1 2026, an estimated $35.6K.
- Amgen made up 0.29% of Beech Hill Advisors's portfolio in Q1 2026, its #75 holding.
- Beech Hill Advisors first reported a position in Amgen in Q4 2016 and has held it in 38 quarters since.
- Beech Hill Advisors's Amgen position peaked at $672K in Q2 2024.
- 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Beech Hill Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.